AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar pchop123 (79.78) Submitted: 1/25/2013 5:26:15 PM : Underperform Start Price: $2.97 AVNR Score: -6.50

Price has moved up beyond reasonable

Featured Broker Partners


Advertisement